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ABSTRACT. The objective of this study was to develop a validated high-performance thin layer 
chromatography (HPTLC) method for the concurrent analysis of two diterpenes Sugiol (compound 1) and 11,14-
dihydroxy-8,11,13-abietatrien-7-one (compound 2) in Plectranthus barbatus chloroform extract (PBCE) and to 
investigate cytotoxicity of both compounds. The chromatographic estimations were carried out using toluene : 
ethyl acetate : formic acid (8.2:1.3:0.5 v/v/v) as mobile phase. The compact spots of biomarkers were scanned at 
λmax= 275 nm. Cytotoxic evaluation of both compounds was performed using follicular thyroid cancer cells (FRO 
cells). A well resolved, compact and intense peaks of compound 1 (Rf = 0.550 ± 0.001) and compound 2 (Rf = 
0.700 ± 0.002) were recorded. The proposed method for both compounds was recorded as simple, linear, precise 
(% RSD = 1.02-1.25), accurate (98-100%), robust and sensitive for the analysis of both compounds. Cytotoxicity 
evaluation showed significant cell cytotoxicity at 100 μg/mL concentration against the FRO cancer cells after 72 h 
of incubation. Both compounds were recorded as cytotoxic, however compound 1 showed significant cytotoxic 
effects. The proposed HPTLC method was found to be suitable for routine analysis of these two biomarkers in 
chloroform extract of P. barbatus. Both compounds were found to be cytotoxic against FRO cancer cells. 
  




Plectranthus barbatus Andr. belonging to family Lamiaceae, is a perennial herb native to the 
India and tropical Africa, which was naturalized in the Egypt, Saudi Arabia, Pakistan, Sri 
Lanka, Brazilian Northeast and Southeast regions [1-3]. This plant has a long history of uses by 
traditional Hindu and Ayurvedic medicines as well as in the folk medicine of Brazil, tropical 
Africa and China with potential benefits [4]. In the literature, P. barbatus has been ascribed to 
possess wide range of medicinal uses which includes gastrointestinal disorders, heart diseases 
such as hypertension and central nervous system (CNS) disorders, respiratory disorders, genito-
urinary, skin affections, congestive heart failure, eczema, colic, asthma, angina and psoriasis [5, 
6]. A decoction of P. barbatus leaves are used in colds, coughs, infections, aetiologies and 
inflammation [7]. Clinical studies on organic extracts of different parts of P. barbatus has 
demonstrated multiple pharmacological activities such as antimicrobial [8], hypotensive [3, 9], 
cytotoxic [10], anti-inflammatory [11], antioxidant [12], hepatoprotective [13], antifeedant [14], 
lipolysis induction in rat adipose tissue [15], total body weight reduction in rats [16], prevention 
of hair-loss and activation of melanogenesis process [17], antiasthmatic [18], antiaging [19] and 
antiallergic [20] effects. The aqueous extract of P. barbatus showed significant hypotensive, 
antispasmodic and hypoglycemic effects [21]. Also the aqueous extract of stem and leaves has 
been reported to enhance the intestinal transit in mice, protected against gastric lesions induced 
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by ethanol or cold-restraint stress [22, 23] and reduced the total pH gastric secretion in pylorus-
ligated rats [1]. The ethanolic root extract of P. barbatus exhibited potential inhibitory effects 
against Escherichia coli toxin-induced secretory response in Guinea pig and rabbit sileal loops 
[24] whereas 50 % ethanolic extract showed a variety of toxic effects on different periods of 
pregnancy in rats [25]. However, the essential oil extracted from leaves has reported to exhibit 
potential antimicrobial, spasmolytic and relaxant effects [21, 25]. Other significant uses of P. 
barbatus are as a food supplements, in Kenya and Yemen, leaves are being consumed as 
vegetable, as an ornamental plant or garden herb, in hedges, fences or boundary markers [26]. 
Phytochemical investigation of different parts of plant material revealed the presence of 
diterpenoids (abietane and labdane), flavonoids, phenolic compounds, tannins, phlobatannins, 
sapnonins, cardiac glycosides and essential oils [27-29]. Studies have shown that the leaves of 
P. barbatus growing in Brazil are rich in abietane diterpenes, whereas the roots of the Indian 
species contain mainly labdane diterpenes such as coleonol and forskolin, main active 
constituent used in number of patented pharmaceutical preparations as an over-the-counter drug 
for the treatment of several ailments [30]. 
In the recent years, high performance thin layer chromatography (HPTLC) has become one 
of the most widely applied analytical techniques for the estimation of chemical and biochemical 
markers in herbal materials. It is due to its numerous advantages which include simplicity, low 
operating cost and good resolution of active constituents with reasonable accuracy in short time, 
possibility of multiple sample detection, high sample throughput and rapidly obtained results 
[31]. The major advantage of HPTLC is that parallel analysis of multiple samples using a small 
amount of mobile phase, unlike HPLC, thus reducing the analysis time and cost of analysis [32]. 
HPTLC chromatogram pattern comparison seems to be promising for fingerprinting the active 
compounds in plant extract. A little information is available regarding analytical methods for the 
qualitative and/or quantitative estimation of sugiol (12-hydroxyabieta-8(14), 9(11),12-trien-7-
one) and 11,14-dihydroxy-8,11,13-abietatrien-7-one (Figure 1). These two abietane diterpene 
occur naturally in many plant species and are reported to possess significant biological activities 
[33, 34]. Studies have shown that sugiol exhibit anti-inflammatory, anti-tumor, antimicrobial 
and aldose reductase inhibitory activities [33-36].  
Consideration the importance of HPTLC and the need for chemical standardization of herbal 
extracts on the basis of isolated chemical entities, especially bioactive ones for global 
acceptances, it was decided to carry out the chemical profiling of chloroform extract of P. 
barbatus on the basis of two bioactive diterpenes. In the present study, we herein report on 
cytotoxic activity of chloroform extract as well as the pure chemical constituents isolated from 
P. barbatus, followed by the development of a sensitive selective hyphenated HPTLC method 






Sugiol ( R1= R3 = H, R2 = OH) 1
11, 14-dihydroxy-8, 11, 13-abietatrien-7-one
           ( R1= R3 = OH, R2 = H) 2  
Figure 1. Molecular structure of sugiol and 11,14-dihydroxy-8,11,13-abietatrien-7-one. 
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Plant material  
 
The aerial parts of P. barbatus Andrews (Lamiaceae) were collected from Makkah roadside, Al-
Taif, Al-Hada region of Saudi Arabia in March 2014. The plant was taxonomically identified 
and authenticated by Dr. Muhammed Yousef, Department of Pharmacognosy, College of 
Pharmacy, King Saud University, Riyadh, Saudi Arabia. A voucher specimen (15732) has been 
deposited in the herbarium of the Department. 
 
Chemicals and reagents  
 
High purity grades of methanol, ethanol and n-hexane were procured from E-Merck (Darmstadt, 
Germany). High purity grades of chloroform and n-butanol were procured from Sigma Aldrich 
(St. Louis, MO, USA). AR grade toluene, ethyl acetate and formic acid were obtained from 
BDH Laboratory Supplies (Poole, UK). FRO thyroid cancer cell line was kindly gifted from 
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.  
 
Extraction of plant material  
 
The air-dried powdered aerial parts of P. barbatus (2000 g) was soaked in 70% ethanol for 
seven days at room temperature, extracted three times in the same solvent and filtered. The 
combined filtrate was concentrated under reduced pressure at 50 ± 5 oC, residue (220.2 g) 
obtained was dissolved in a mixture of methanol and water (9:1) and the resulting solution was 
partitioned successively with n-hexane, chloroform (CHCl3), ethyl acetate (EtOAc) and n-
butanol (n-BuOH) to obtain n-hexane (25.5), CHCl3 (130.6), EtOAc (30.3 g) and n-BuOH (10.9 
g) fractions, respectively. The CHCl3 soluble fraction (120 g) rich in quantity and chemical 
constituents was subjected to gravity column chromatography. It was dissolved in minimum 
amount of methanol, uniformly adsorbed over 200 g of silica gel (230-400 mesh) and freed from 
solvent to obtain free flowing material. A glass column was packed with 500 g of SiO2 gel (230-
400 mesh) in n-hexane–CHCl3 and successively eluted with hexane–CHCl3 (9:1), hexane–
CHCl3 (8:2), hexane–CHCl3 (7:3), hexane–CHCl3 (6:4), CHCl3 and then MeOH. The combined 
10 and 20% CHCl3 in n-hexane fractions (23.0 g) was re-chromatographed over SiO2 (230-400 
mesh (E-Merck, Darmstadt, Germany) using hexane–CHCl3 mixtures of increasing polarity. A 
total of 220 fractions (150 mL each) were collected. Fractions 25-45 obtained from hexane–
CHCl3 (9:1) were pooled on the basis of similar TLC pattern using CHCl3:MeOH (98:2) as a 
developing solvent and spots were visualized by spraying plate with p-anisaldehyde:H2SO4 (0.5 
mL p-anisaldehyde in 50 mL glacial acetic acid and 1 mL 97% H2SO4) followed by heating over 
hot plate for 5 min at 110 oC. Sugiol (23.2 mg) was crystallized from MeOH as colorless 
crystals (m.p. 283-284 oC; C20H28O2. ESIMS: m/z = 323 [M+Na]
+, m/z = 301[M+H]+, 1H and 
13C-NMR) [37]. Similarly, fractions eluted in 30 % chloroform in hexane resulted in the 
isolation of another abietane diterpene, identified as 11,14-dihydroxy-8,11,13-abietatrien-7-one, 
crystallized in MeOH as yellow needles (m.p. 178-180 oC; C20H28O3. ESIMS: m/z =339 
[M+Na]+, 1H and 13C-NMR) [38]. The structures of both the compounds were confirmed by 
comparisons of physical constants and spectral data of with previously reported values in 
literature [37, 38]. 
 
Apparatus and reagents 
 
The two cytotoxic diterpene biomarkers sugiol (1) and 11,14-dihydroxy-8,11,13-abietatrien-7-
one (2) were isolated as pure compound from P. barbatus. In addition, the AR grade toluene, 
ethyl acetate and formic acid were purchased from BDH (Poole, UK). The glass-backed silica 
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gel 60F254 plates for the HPTLC analysis were purchased from E-Merck (Darmstadt, Germany). 
Furthermore, biomarkers compound 1 and 2 along with extract (PBCE) were applied band wise 
to the chromatographic plates using CAMAG Automatic TLC Sampler-4 (Switzerland) and the 
plates were development in automatic development chamber (ADC2) (Switzerland). The 
developed HPTLC plates were then scanned and documented by CATS 4 (CAMAG) and TLC 
Reprostar 3 (CAMAG), respectively.  
 
HPTLC instrumentation and conditions 
 
The HPTLC analysis of compounds 1 and 2 in PBCE was carried out on 10 × 10 cm HPTLC 
plates, where the band size of each track was 6 mm wide and 7.0 mm apart. Both the markers as 
well as the extract were applied on HPTLC plate at a rate of 160 nL/s using microlitre syringe 
fitted with the automatic TLC Sampler-4. The plates were developed in a pre-saturated twin-
trough glass chamber (20 × 10 cm) under the chamber saturation condition (at 25 ± 2°C and 
under 60 ± 5% humidity). Further, the developed HPTLC plates were dried to furnish compact 
spots of the biomarkers as well as the different phytoconstituents present in the extract. The 
mixture of toluene: ethyl acetate: formic acid (8.2:1.3:0.5 v/v/v) was used as a mobile phase. 
The dried plate was quantitatively analyzed at λmax = 275 nm wavelength in absorbance mode.  
 
Preparation of standard stock solutions 
 
The stock solutions of compound 1 and 2 (1 mg/mL) were prepared in chloroform, following 
further dilution with chloroform to provide seven different concentrations ranging from 10 to 
120 μg/mL. 10 μL of each dilution of both biomarkers were applied on the HPTLC plate 
through the microliter syringe attached with the applicator to provide the linearity range of 100-
1200 ng/band.  
 
Validation of method  
 
The proposed HPTLC method was validated for the determination of limit of detection (LOD), 
limit of quantification (LOQ), linearity range, precision, recovery as accuracy and robustness 
according to International Conference on Harmonization (ICH) guidelines [39]. ICH guidelines 
are generally used for validation of such studies [39-42]. The detail procedure about 




Undifferentiated/anaplastic thyroid cancer cell line (FRO) was kindly gifted from King Faisal 
Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. The cells were cultured in 
humidified air with 5% CO2 at 37 
oC in RPMI-1640 medium with L-glutamine and sodium 
bicarbonate (R8758, Sigma Aldrich, St. Louis, MO, USA) and supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin-streptomycin both from (Gibco).  
The cancer cell lines were maintained in RPMI-1640 that included L-glutamine (GIBCO) 
with 10% FBS (GIBCO) and 1% penicillin–streptomycin (GIBCO). Cells were cultured at 37 oC 
in a 5% CO2 incubator [45, 46]. The effect of chloroform extract of plant (PBCE) along with 
pure isolated compounds 1 and 2 were evaluated on cellular viability using Alamar Blue assay 
(BUF012B; AbDSerotec, Langford Ln, Kidlington OX5 1GE, UK). The Alamar Blue assay is 
used to assess cell viability based on the reduction potential of metabolically active cells. Viable 
cells were seeded in the growth medium into 96-well microtiter plates (1 x 104 cells/well) and 
were incubated at 37 oC in a 5% CO2 incubator for 24 h. The extract (PBCE), compounds 1 and 
2 were adjusted to final 30, 50 and 100 μg/mL concentrations by diluting with the growth 
medium. After standing for 24 h, media were removed and the test sample was added to each 
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well. Control wells consisted of cells alone. After 24, 48 and 72 h of addition of test sample, 10 
µL of Alamar Blue reagent was added to the each well (final concentration, 10 μg/mL) and the 
plates were incubated at 37 oC for 4 h. After incubation, plates were read using a 
spectrophotometric microplate reader (Biotek Synergy 2; Biotek Instruments, Highland Park, 
Winooski, Vermont, NE, USA) and the relative fluorescence unit was recorded. Cell viability 





× 100                            (1) 
 




The statistical analysis was carried out by one-way analysis of variance (ANOVA) followed by 
Dunnet’s test for the estimation of total variation in a set of data. Results were expressed as 
mean ± SD. p <0.01 was considered significant. 
 
RESULTS AND DISCUSSION 
 
HPTLC method development and validation 
 
The mobile phase selection for the HPTLC analysis was carried out by testing various 
compositions of different solvents. Of these, the combination of toluene: ethyl acetate: formic 
acid (8.2:1.3:0.5 v/v/v) was found to be the best mobile phase for the development and 
quantitative analysis of compound 1 and 2. An intense, sharp and compact peak of compounds 1 
and 2 were found at Rf = 0.550 ± 0.001 and 0.700 ± 0.002, respectively (Figure 2). 
 
 
Figure 2. Chromatogram of compound 1 (Rf = 0.550 ± 0.001) and compound 2 (Rf = 0.700 ± 
0.002) at λmax =275 nm; mobile phase: toluene: ethyl acetate: formic acid (8.2:1.3:0.5 
v/v/v). 
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This method clearly separated the biomarkers compound 1 and 2 as well as different 
constituents of PBCE (Figure 3A and B).  
 
Figure 3. Quantification of compound 1 and compound 2 in the chloroform extract of P. 
barbatus (PBCE) by HPTLC; (A) pictogram of HPTLC plate at short UV (λ = 254 
nm) and (B) 3-D display of all tracks at λ = 275 nm. 
 
The mobile phase volume and optimized saturation time for the saturation of developing 
chamber were found to be 20 mL and 20 min, respectively. The identities of the bands of the 





Figure 4. Spectral comparisons of different tracks at 275 nm (different color codes represent 
different concentrations of compounds). 
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The developed method was found to be quite selective with high baseline resolution. The 
regression equation/correlation co-efficient (r2) for compounds 1 and 2 were found as y = 6.32 x 
+ 552/0.996 ± 0.0004 and y = 11.1 x + 760/0.998 ± 0.0002, respectively, in the linearity range of 
100-1200 ng/spot while the LOD/LOQ for compounds 1 and 2 were found as 9.96/30.1 ng/band 
and 13.1/39.7 ng/band, respectively. The recoveries as accuracy study for the proposed method 
was recorded (Table 1). The % recovery/RSD (%) for compounds 1 and 2 were found to be 
98.4-100/1.18-1.63 and 98.0-99.5/1.51-2.15, respectively. % RSD for intra-day/inter-day 
precisions (n = 6) of compounds 1 and 2 were recorded as 1.07-1.19/1.02-1.15 and 1.06-
1.25/1.04-1.22, respectively, which exhibits the good precision of the proposed method. The 
robustness of proposed method was checked by making a small deliberate change in the mobile 
phase composition, saturation time and mobile phase volume and the obtained data are reported 
in the Table 3. The low values of % RSD indicated that the proposed method was robust. 
 
Table 1. Recovery as accuracy studies of the proposed HPTLC method (n = 6). Comp. 1: Compound 1; 
Comp. 2: Compound 2 
 
Table 2. Precision of the proposed HPTLC method (n = 6). 
 
 
Table 3. Robustness of the proposed HPTLC method (n = 6). 
 
Optimization condition Compound 1 (400 ng/band) Compound 2 (400 ng/band) 
                SD                SD 
Mobile phase composition;  
(toluene: ethyl acetate: formic acid) 
  
(8.2:1.3:0.5) 4.59 4.62 
(7:2.3:0.7) 4.63 4.52 
(6.4:3.2:0.4) 4.69 4.58 
Mobile phase volume (for saturation)   
(18 mL) 4.38 4.52 
(20 mL) 4.35 4.55 
(22 mL) 4.31 4.57 
Duration of saturation   
(10 min) 4.55 4.51 
(20 min) 4.51 4.53 
(30 min) 4.59 4.56 
 
 
Percent (%) of   
Comp. 1 and Comp. 2 
added to analyte 
Theoretical concentration 
of   Comp. 1 and Comp. 
2 (ng/mL) 
Concentration found 
(ng/mL) ± SD 
% Recovery 
Comp. 1 Comp. 2 Comp. 1 Comp. 2 
0 200 197 ± 3.21 196 ± 4.21 98.4 98.0 
50 300 301 ± 4.26 299 ± 5.51 100 99.5 
100 400 395 ± 4.86 395 ± 6.71 98.7 98.8 
150 500 498 ± 5.91 496 ± 7.49 99.6 99.1 
Conc. 
(ng/spot) 
Compound 1 Compound 2 
Intra-day precision Inter-day precision Intra-day precision Inter-day precision 
Mean conc.  
found  ± SD 
Mean conc.  
found  ± SD 
Mean conc.  
found  ± SD 
Mean conc.  
found  ± SD 
400 395 ± 4.24 392 ± 4.01 397 ± 4.25 395 ± 4.14 
600 601 ± 6.87 596 ± 6.59 597 ± 6.82 595 ± 6.69 
800 797 ± 9.51 792 ± 9.13 797 ± 9.98 795 ± 9.73 
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The intra-day and inter-day precision for the proposed method is recorded in Table 2 and the 
HPTLC is an advanced form of instrumental TLC which has various advantages in comparison 
to other techniques like HPLC and other chromatographic methods in the analysis of different 
markers. By using HPTLC method, many samples can be separated on the same HPTLC plate 
simultaneously which resulted in high through-put and lowered operating cost. The compounds 
having different light absorption capacity or colors can also be identified using different mode 
of evaluation by HPTLC. The plates used in the HPTLC analysis are disposable hence it does 
not require regeneration or essential clean-up. The availability of many stationary phases has 
expanded the HPTLC application to various kinds of samples contrary with the separation on 
bare silica gel. The HPTLC technique is applied in qualitative and quantitative separations of 
compounds in mixtures, where the quantitative mode operates in a more optimized way 
(standardized with a given procedure) and hence applicable in the assay of compounds in 
samples [47-49]. 
 
HPTLC analysis of compound 1 and compound 2 
 
The developed HPTLC method was used for the concurrent analysis of compounds 1 and 2 in 
the extracts PBCE (Figure 5). By applying the above developed method, the quantity of 
compound 1 and 2 in PBCE were found as 2.04 and 15.9 μg/mg, respectively, of the dried 
weight of extracts. This is a maiden report which demonstrated the development of an 
economical, precise, accurate and simple HPTLC method for the concurrent analysis of 
cytotoxic biomarkers sugiol (1) and 11,14-dihydroxy-8,11,13-abietatrien-7-one (2) in the 
chloroform extract of P. barbatus (PBCE). 
 
 
Figure 5. Chromatogram of chloroform extract of P. barbatus (PBCE) at λ = 275 nm; [compound 
1, spot 10, Rf = 0.55; compound 2, spot 12, Rf = 0.70)]. 
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Cytotoxicity of chloroform extract of P. barbatus along with sugiol (1) and 11,14-dihydroxy-8, 
11,13-abietatrien-7-one (2) were evaluated using Alamar Blue assay. The Alamar Blue assay 
was used to assess cell viability and cell proliferation and is based on the reduction potential of 
metabolically active cells. The effect of chloroform extract of P. barbatus (PBCE), compound 1 
and 2 on FRO cells viability at different concentrations (30, 50 and 100 μg/mL) at different time 
intervals (24, 48 and 72 h) is demonstrated in Figure 6 A, B and C. As shown in Figure 6A-C, 
there was no significant alteration in cells viability at 30 μg/mL concentration of extract while 
some reduction in the viability of FRO cells was observed at 50 μg/mL and 100 μg/mL 
concentration of the extract after incubation of cells for 48 (Figure 6B) and 72 h (Figure 6C) 
periods, respectively. At 100 μg/mL concentration of extract, cells viability reduction was the 
most for extract after 24, 48 and 72 h, respectively (Figure 6A-C). However significant cell 
cytotoxicity was observed with compound 1 at concentration of 30 μg/mL at 24, 48, and 72 h 
(Figure. 6A-C). However, no signs of cytotoxicity were observed for compound 2 at 30 μg/mL 
concentration. Meanwhile at 50 μg/mL concentration, compound 2 showed around 40% 
reduction in cell viability and even more cytotoxicity was observed for compound 2 at higher 
concentrations (100 μg/mL) as represented in Figure 6A-C. Thus our results clearly show that 




Figure 6. Cell viability (%) of FRO cells after incubation with extract, compound 1 and 2 in a 
dose dependent manner; cell viability of FRO cells with extract, compound 1, and 
compound 2 along with control at 30, 50 and 100 µg/mL concentrations after (A) 24 h, 
(B) 48 h and (C) 72 h incubation assessed using Alamar Blue assay. Results are 
expressed as % mitochondrial activity for the Alamar Blue assay. Results are presented 
as mean ± SD, n = 3. 
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The results of cytotoxicity evaluation in terms of maximum inhibition (MI) and IC50 are 
furnished in Table 4 [46]. The values of IC50 and MI for extract, compound 1 and compound 2 
were determined by concentration-dependent cell viability curves shown in Figure 6A-C. The 
MI value for extract was recorded as 42.2 ± 8.00, 28.2 ± 1.50 and 28.2 ± 7.86 after 24, 48 and 
72 h, respectively. However, the MI value for compound 1 was recorded as 96.3 ± 5.60, 96.2 ± 
1.04 and 96.5 ± 1.88% after 24, 48 and 72 h, respectively, which were significant in comparison 
with extract (p < 0.05). On the other hand, the MI value for compound 2 was recorded as 75.0 ± 
1.08, 91.5 ± 1.64 and 95.2 ± 2.02% after 24, 48 and 72 h, respectively, which were also 
significant in comparison with extract (p < 0.05). Overall, compound 1 was found to be more 
efficacious than extract and compound 2 against FRO cells. Control sample indicated cell 
growth at negligible extent (Figure 6). The IC50 value of extract was obtained as 128, 165 and 
166 µg/mL after 24, 48 and 72 h, respectively. However, the IC50 value for compound 1 was 
recorded as 18.4, 18.5 and 31.2 µg/mL after 24, 48 and 72 h, respectively. On the other hand, 
the IC50 value for compound 2 was recorded as 72.1, 61.9 and 55.5 µg/mL after 24, 48 and 72 h, 
respectively. The IC50 value of compound 1 was significantly lower than extract and compound 
2.  
 
Table 4. IC50 and MI values of extract, compound 1, compound 2 and control on FRO cells after 24, 48 and 




IC50 (µg/mL) ± SD MI (%) ± SD 
24 h 48 h 72 h 24 h 48 h 72 h 
Extract 128 ± 6.45 165 ± 4.27 166 ± 5.91 42.2 ± 8.00 28.2 ± 1.50 28.2 ± 7.86 
Compound 1 18.4 ± 0.92 18.5 ± 0.83 31.2 ± 1.57 96.3 ± 5.60 96.2 ± 1.04 96.5 ± 1.88 
Compound 2 72.1 ± 2.58 61.9 ± 2.22 55.5 ± 2.36 75.0 ± 1.08 91.5 ± 1.64 95.2 ± 2.02 
Control - - - 1.00 ± 0.20 1.00 ± 0.20 1.00 ± 0.20 
Standard deviation (SD); the percent of maximum inhibition (% MI); the concentration responsible for 50% of cell 
inhibition (IC50). 
 
The cytotoxicity activity evaluation of the chloroform extract of the plant (100 μg/mL at 72 
h) showed enough reduction in the viability of undifferentiated FRO cells. The two abietane-
type diterpenes viz., 12-hydroxyabieta-8(14),9(11),12-trien-7-one (1) and 11,14-dihydroxy-
8,11,13-abietatrien-7-one (2) were found to be cytotoxic. However, compound 1 showed 
significant cytotoxic effects at different time intervals.  
Cytotoxicity studies suggested that compound 1 was around four fold more efficacious in 
comparison with extract after 24 and 48 h of incubation period. Overall, compound 1 was found 
to be more potent than extract and compound 2. Therefore, compound 1 could be formulated in 




The maiden HPTLC method developed for the concurrent analysis of cytotoxic biomarkers 
sugiol and 11,14-dihydroxy-8,11,13-abietatrien-7-one in the P. barbatus extract may be further 
employed in the analysis of these biomarkers in extracts of other species of same genus as well 
as different genus to establish the chemotaxonomic relationship. The above developed method 
can also be used in the quantitative analysis of these two cytotoxic biomarker in marketed 
preparations, quality control of herbal drugs containing these two biomarkers and study of their 
degradation kinetics. Cytotoxicity evaluation indicated that compound 1 was more efficacious in 
comparison with extract. Overall, compound 1 was found to be more potent than extract and 
compound 2. Hence, compound 1 could be formulated in different dosage forms for the 
chemoprevention of cancers in future studies.  
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